ST. PETERSBURG, FL / ACCESSWIRE / June 3, 2019 / Medical Research Collaborative, LLC (MRC) announces the recent launch of their website, MedicalResearchCollaborative.com.
MRC offers comprehensive segmental market research that includes companies comprising the global healthcare market, segmented into product type by sponsor and by end user. By the mode of product type, the market has been segmented into finished products, active pharmaceutical ingredients and indications approved/sought. The analysis also covers barriers to entry, ongoing patent infringement proceedings, competition and loopholes available to smaller competitors. The analysis further divides amongst products and infers the likelihood and type of regulatory action.
For more information on Medical Research Collaborative reports, please visit: https://medicalresearchcollaborative.com/reports
About Medical Research Collaborative
Medical Research Collaborative, LLC, as the name implies, is a collaborative effort, bringing together expertise from various fields of scientific endeavor, as well as in matters of foreign and domestic (U.S.) patent law and regulatory science, directly applicable to a systematic, thorough analysis of companies in the healthcare sector and their products.
CONTACT
James Murphy
Executive Director of Marketing
Medical Research Collaborative, LLC
Phone: 1-877-427-1317
Email: admin@medicalresearchcollaborative.com
Web: https://medicalresearchcollaborative.com/
Source: https://medicalresearchcollaborative.com/
SOURCE: Medical Research Collaborative, LLC
View source version on accesswire.com:
https://www.accesswire.com/547472/Medical-Research-Collaborative-LLC-Announces-Launch-of-Website-Offering-Market-Research-on-the-Global-Healthcare-Sector
LOS ANGELES, Jan. 11, 2025 /PRNewswire/ -- Demonstrating a commitment to both innovation and compassion,…
SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced…
BEDMINSTER, N.J. , Jan. 10, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American:…
Craig Swandal, experienced medical device manufacturing executive, joins leadership teamALACHUA, Fla. and TAMPA, Fla., Jan.…
WALTHAM, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage…
SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”),…